April 1, 2024Kidney International ReportsOpen Access

Wcn24-614 a Comparison of Early- And Long-Term Graft Survival Between Cyclosporine- And Tacrolimus-Based Immunosuppressive Therapies in Kidney Transplantation: Experience in a Tertiary Care Hospital of Banglade

View Full Paper

Ask AI

Bookmark

Evaluation focuses on early- and long-term graft survival, comparing cyclosporine- against tacrolimus-based immunosuppressive therapy in kidney transplantation recipients.
Analyses target individuals with end-stage renal disease, evaluating clinical graft outcomes managed with two distinct calcineurin inhibitors at a tertiary care hospital.
Comparative assessment highlights calcineurin inhibitors as essential immunosuppressive therapy, supporting optimized long-term graft management in kidney transplantation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Tertiary care evaluation reports graft survival in kidney transplant recipients, highlighting outcomes between cyclosporine- and tacrolimus-based regimens.

Cite This Study

Khoda et al. (2024) studied this question.

synapsesocial.com/papers/68e713c8b6db64358768c6a3 https://doi.org/10.1016/j.ekir.2024.02.934

View Full Paper

Ask AI

Bookmark

Implication

Tertiary care evaluation reports graft survival in kidney transplant recipients, highlighting outcomes between cyclosporine- and tacrolimus-based regimens.

Wcn24-614 a Comparison of Early- And Long-Term Graft Survival Between Cyclosporine- And Tacrolimus-Based Immunosuppressive Therapies in Kidney Transplantation: Experience in a Tertiary Care Hospital of Banglade

Key Points

Discussion

Implication

Cite This Study

Wcn24-614 a Comparison of Early- And Long-Term Graft Survival Between Cyclosporine- And Tacrolimus-Based Immunosuppressive Therapies in Kidney Transplantation: Experience in a Tertiary Care Hospital of Banglade

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider